vimarsana.com

Page 15 - முதலீட்டாளர் உறவுகள் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SPX Corporation (SPXC) Q1 2021 Earnings Call Transcript

SPX Corporation (SPXC) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. SPX Corporation (NYSE: SPXC) Operator Thank you for standing by and welcome to the Q1 2021 SPX Corporation Earnings Conference Call. At this time, all participants are in only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the call over to Paul Clegg, VP of Investor Relations and Communications. Please, go ahead.SPONSORED: 10 stocks we like better than SPX When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

Prothena Corporation plc: Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Prothena Corporation plc: Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, May 07, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise, today announced that in connection with hiring two new employees, the compensation committee of the Company s board of directors granted the individuals hired by the Company, in the aggregate, options to purchase 155,000 ordinary shares of the Company. The options have an exercise price per share equal to $27.04, which was the closing trading price on May 3, 2021, the date of the grants. The inducement awards will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the date of grants and 1/48th of the underlying shares vesting monthly thereafter over 36 months. The options were granted pursuant to the Company s 2020 Employmen

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Investegate |Lucara Diamond Corp Announcements | Lucara Diamond Corp: RESULTS FOR THE FIRST QUARTER OF 2021

    Lucara Diamond Corp. ( Lucara or the Company ) today reports its results for the first quarter of 2021 ending March 31, 2021, with strong financial and operational performance.   HIGHLIGHTS: · Revenue of $53.1 million or $579 per carat sold in Q1 2021, 56% higher than Q1 2020.  This includes diamonds sold through a combination of regular tenders, Clara, and through HB Antwerp ( HB ) under the supply agreement announced in July 2020. · Q1 2021 total operating cash costs of $29.24 per tonne processed (1), 7% lower than Q1 2020.  · Adjusted EBITDA (1) in Q1 2021 of $22.2 million, marking a return to higher levels of operating margin. · Extension of the Karowe mining license for a period of 25 years to 2046, marking a critical step in the advancement of the Karowe underground expansion project.

Noreco: Successful Closing of USD 1 1 Billion Reserve Based Lending Facility

Noreco: Successful Closing of USD 1.1 Billion Reserve Based Lending Facility OSLO, Norway, May 5, 2021 /PRNewswire/ Norwegian Energy Company ASA ( Noreco or the Company ) announces the successful closing of its new USD 1.1 billion Reserve Base Lending facility (the Facility ), replacing the Company s existing USD 900 million RBL. Effective today, the Facility matures in 2028 with a seven-year term that will amortize from the second half of 2024. The margin payable under the Facility remains in line with the borrowing cost of the existing RBL and the Facility also includes an Accordion option of up to USD 400 million that may be used to support potential future commercial opportunities.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.